3 Growth Stocks for April 2021

Growth stocks like Topicus (TSXV:TOI) should be on your radar for 2021.

| More on:
Upwards momentum

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Growth stocks are having a tough year. Most have seen double-digit declines since January. Investors are clearly pivoting to value stocks with robust cash flows this year. This means investors can finally find growth stocks trading at reasonable valuations. 

Here are the top three growth stocks that seem undervalued and genuinely promising for the second-half of 2021. 

Growth stock #1

WELL Health Technologies (TSX:WELL) was a Bay Street darling throughout last year. This year, the tables have turned. WELL Health stock has tumbled 25% from its all-time high set in late-February. The company is now worth $1.35 billion, which is just four times greater than its expected annual revenue run rate for 2021. 

In other words, the forward price to sales ratio is four. Meanwhile, WELL Health is on pace to greatly expand its network across the United States: a critical market for telehealth services. 

Over the long-run, the company’s online pharmacy, telehealth services and medical data businesses have multi trillion-dollar market opportunities. There’s room to grow and WELL Health’s team already has a track record of exceptional execution. Now that the valuation is lower, it could be an ideal growth stock for investors.  

Growth stock #2

Topicus (TSXV:TOI) is another reasonably-priced growth stock in the tech sector. However, unlike the other stocks on this list the stock hasn’t tumbled in recent months. The stock has lost just 6% of its value since hitting an all-time high. That’s because it’s already under the radar. 

The company is a spin-off from Constellation Software, the enterprise software conglomerate. Unlike its parent company, Topicus focuses on vertical software acquisition targets in Europe. Small and medium-sized software firms in Europe tend to have better valuations than their North American counterparts.  

Topicus generated €494.0 million (CA$727 million) in revenue and €63.7 million (CA$94 million) in net income over the past year. This year, net income could expand by 30% to 40% yet again. Effectively, Topicus stock is trading at a forward price-to-earnings ratio of just 28.4, which is significantly lower than the software industry’s average. 

Growth stock #3

Canada Goose (TSX:GOOS)(NYSE:GOOS) is the only non-tech stock on this list, but it’s exposure to China and growing e-commerce platform earns it a spot. The stock is up 153% since the pandemic erupted last year. It’s now trading at a forward price-to-earnings ratio of 26.5. 

However, the P/E-to-Growth or PEG ratio is less than 1. That’s because Canada Goose expects high double-digit growth in the years ahead. The company is vastly expanding its footprint in China, a critical market for luxury retail. It’s also investing heavily in its e-commerce platform, which should improve margins and sales. 

Last year the company introduced lighter jackets and coats to its collection for the first time. This means it is expanding beyond the ultra-thick winter jackets that made it famous. It also means that the Canada Goose brand can expand to countries with much milder winters. 

In short, this is a growth stock that deserves a spot on your watch list for 2021. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns shares of WELL Health Technologies. The Motley Fool owns shares of and recommends Constellation Software and Topicus.Com Inc. The Motley Fool recommends Canada Goose Holdings.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »